Dr. Labiento Smith controls early myopia progression with low-dose Atropine and/or Orthokeratology. She bases her treatment on the current literature and recent LAMP study. These treatments for myopia control are considered an off-label use in the United States.. The medication Atropine and Ortho-K are FDA approved but under a different category and use. All children with active myopia progression at Sudbury Eye Care are seen bi-annually for exams to monitor progression.
Dr. L. As I call her is the best around! I have a very difficult prescription and schedule. She not only figured out my prescription which has two levels but, she also spent a long time trying to assist me in wearing contacts. Dr Smith is very accommodating. I am never rushed when I am there. I also have great frames thanks to her as well! Dr L does both pediatric and adult eye care and is well worth the trip if you aren’t from Sudbury !!! Thank you Dr L for the great care!!
Kathleen D. — Yelp